Treating Nephroblastoma in Rwanda: Using International Society of Pediatric Oncology Guidelines in a Novel Oncologic Care Model
Author(s) -
Cyprien Shyirambere,
Mary Jue Xu,
Shekinah N.C. Elmore,
Temidayo Fadelu,
Leana May,
Neo Tapela,
Denis Gilbert Umuhizi,
Frank Regis Uwizeye,
Caitlin Driscoll,
Clemence Muhayimana,
Vedaste Hategekimana,
Fidel Rubagumya,
Ignace Nzayisenga,
Lawrence N. Shulman,
Tharcisse Mpunga,
Leslie E. Lehmann
Publication year - 2016
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.2015.000067
Subject(s) - medicine , referral , stage (stratigraphy) , disease , pediatric oncology , incidence (geometry) , pediatrics , neutropenia , febrile neutropenia , cancer , chemotherapy , family medicine , paleontology , physics , optics , biology
Success in treating nephroblastoma in high-income countries has been transferred to some resource-constrained settings; multicenter studies report disease-free survival of greater than 70%. However, few reports present care models with rural-based components, care tasks shifted to internists and pediatricians, and data collection structured for monitoring and evaluation. Here, we report clinical outcomes and protocol compliance for patients with nephroblastoma evaluated at Butaro Cancer Center of Excellence in Rwanda.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom